Company: MBIO
Filing Date: 2025-04-04
Form Type: POS AM
Source: 0001104659-25-032236
Chunk: 9

Company: MUSTANG BIO, INC.
Filing Date: 2025-04-04
Form: POS AM
Chunk 9
---
 a result of economic and geopolitical 
 conditions.                                                                                              |

<div align='center'>9</div>

We have based these forward-looking statements
largely on our current expectations, estimates, forecasts, and projections about future events and financial trends that we believe may
affect our financial condition, results of operations, business strategy, and financial needs. In light of the significant uncertainties
in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. Although we
believe that we have a reasonable basis for each forward-looking statement contained in this prospectus, we cannot guarantee that the
future results, levels of activity, performance, or events and circumstances reflected in the forward-looking statements will be achieved
or occur at all. You should refer to the section entitled “Risk Factors” in this prospectus and the documents we incorporate
by reference for a discussion of important factors that may cause our actual results to differ materially from those expressed or implied
by our forward-looking statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material.
Except as required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information,
future events or otherwise.

You should read this prospectus, the documents
incorporated by reference in this prospectus, and the documents filed as exhibits to the registration statement of which this prospectus
is a part completely and with the understanding that our actual future results may be materially different from what we expect. We qualify
all of the forward-looking statements by these cautionary statements.

<div align='center'>10

USE OF PROCEEDS</div>

We will receive the exercise price per share for
each Warrant exercised for cash. However, we are unable to predict the timing or amount of Warrants exercised. If all of the Warrants
are exercised for cash (meaning we issue the maximum possible number of shares of common stock upon exercise of the Warrants), we will
receive gross cash proceeds of approximately $16.6 million. Any proceeds received from the exercise of the Warrants will be used for working
capital and other general corporate purposes.

<div align='center'>11

DESCRIPTION OF CAPITAL STOCK</div>

The following description of our capital stock is not complete and may not contain all the information you should consider before investing in our capital stock. This description is summarized from, and qualified in its entirety by reference to, our amended and restated certificate of incorporation, as amended, and